SK bioscience Co.,Ltd. (302440.KS) on Tuesday reported wider loss for the fourth quarter of 2025, despite higher sales.
The company posted net loss from continuing operations before income tax of 21.316 billion won, compared with a loss of 21.743 billion won in the same period last year.
Operating loss increased to 51.610 billion won, from 50.776 billion won loss a year earlier.
Net loss for the quarter was 57.962 billion won, significantly wider than a loss of 6.437 billion won in the fourth quarter of 2024.
Sales increased to 184.186 billion won from 156.849 billion won a year earlier.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.